Literature DB >> 1442211

Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization.

S J Vargas1, M T Gillespie, G J Powell, J Southby, J A Danks, J M Moseley, T J Martin.   

Abstract

Parathyroid hormone-related protein (PTHrP) has been identified immunohistochemically in 60% of breast carcinoma and in 92% of breast cancer metastases in bone. To establish whether the localization of the PTHrP antigen reflects protein synthesis and also to investigate the role of PTHrP in metastatic disease, as part of an ongoing study, we used in situ hybridization to study the localization of PTHrP mRNA in a retrospective series of primary breast tumors and their metastatic lesions. Paraffin sections of 17 primary and 26 metastatic lesions, 11 of which were in bone, were available for the study: 10 of the 17 (59%) primary lesions, 8 of 11 (73%) breast cancer metastases to bone, and 3 of 15 (20%) metastases to non-bone sites showed specific localization of PTHrP mRNA. These findings establish that PTHrP is commonly synthesized by primary breast cancers and support previous immunohistochemical studies reporting a higher incidence of PTHrP-positive tumor cells in skeletal metastases than in nonskeletal metastases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442211     DOI: 10.1002/jbmr.5650070814

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  28 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Strategies for management of prostate cancer-related bone pain.

Authors:  R C Pelger; V Soerdjbalie-Maikoe; N A Hamdy
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Parathyroid hormone-related protein: a developmental regulatory molecule necessary for mammary gland development.

Authors:  M E Dunbar; J J Wysolmerski
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 4.  EGFR signaling in breast cancer: bad to the bone.

Authors:  John Foley; Nicole K Nickerson; Seungyoon Nam; Kah Tan Allen; Jennifer L Gilmore; Kenneth P Nephew; David J Riese
Journal:  Semin Cell Dev Biol       Date:  2010-09-09       Impact factor: 7.727

5.  Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma.

Authors:  Makoto Tsuchimochi; Ayako Kameta; Mikiko Sue; Masataka Katagiri
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

6.  Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression.

Authors:  M Ito; M Nakashima; G K Alipov; S Matsuzaki; A Ohtsuru; H Yano; S Yamashita; I Sekine
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

7.  Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro?

Authors:  A Tabuenca; S Mohan; C A Garberoglio; P I Borgen; T Rosol; T A Linkhart
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Analysis of the ERK1,2 transcriptome in mammary epithelial cells.

Authors:  Constance Grill; Ferdous Gheyas; Priya Dayananth; Weihong Jin; Wei Ding; Ping Qiu; Luquan Wang; Ronald J Doll; Jessie M English
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

9.  Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries.

Authors:  T Benson; T Menezes; J Campbell; A Bice; B Hood; R Prisby
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

Review 10.  Medical treatment of tumor-induced hypercalcemia and tumor-induced osteolysis: challenges for future research.

Authors:  J J Body
Journal:  Support Care Cancer       Date:  1993-01       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.